Citation: Pa. Flordal et D. Bergqvist, POSSIBLE BENEFIT OF PREOPERATIVE BLOOD-DEPOSIT FOR ABDOMINAL-SURGERY, World journal of surgery, 21(4), 1997, pp. 349-352
Citation: Pa. Flordal, PHARMACOLOGICAL PROPHYLAXIS OF BLEEDING IN SURGICAL PATIENTS TREATED WITH ASPIRIN, European journal of anaesthesiology, 14, 1997, pp. 38-41
Authors:
FLORDAL PA
BERGQVIST D
BURMARK US
LJUNGSTROM KG
TORNGREN S
Citation: Pa. Flordal et al., RISK-FACTORS FOR MAJOR THROMBOEMBOLISM AND BLEEDING TENDENCY AFTER ELECTIVE GENERAL SURGICAL OPERATIONS, The European journal of surgery, 162(10), 1996, pp. 783-789
Authors:
BERGQVIST D
FLORDAL PA
FRIBERG B
FRISELL J
HEDBERG M
LJUNGSTROM KG
MATZSCH T
TORNGREN S
Citation: D. Bergqvist et al., THROMBOPROPHYLAXIS WITH A LOW-MOLECULAR-WEIGHT HEPARIN (TINZAPARIN) IN EMERGENCY ABDOMINAL-SURGERY - A DOUBLE-BLIND MULTICENTER TRIAL, VASA, 25(2), 1996, pp. 156-160
Authors:
HEDSTROM M
FLORDAL PA
AHL T
SVENSSON J
DALEN N
Citation: M. Hedstrom et al., AUTOLOGOUS BLOOD-TRANSFUSION IN HIP-REPLACEMENT - NO EFFECT ON BLOOD-LOSS BUT LESS INCREASE OF PLASMINOGEN-ACTIVATOR INHIBITOR IN A RANDOMIZED SERIES OF 80 PATIENTS, Acta orthopaedica Scandinavica, 67(4), 1996, pp. 317-320
Authors:
FLORDAL PA
BERGQVIST D
BURMARK US
LJUNGSTROM KG
TORNGREN S
Citation: Pa. Flordal et al., MAJOR THROMBOEMBOLISM AND DIFFUSE BLEEDING AFTER ELECTIVE GENERAL ABDOMINAL-SURGERY - CLINICAL RISK-FACTORS, Thrombosis and haemostasis, 73(6), 1995, pp. 1096-1096
Authors:
FLORDAL PA
BERGQVIST D
LJUNGSTROM KG
TORNGREN S
Citation: Pa. Flordal et al., CLINICAL RELEVANCE OF THE FIBRINOGEN UPTAKE TEST IN PATIENTS UNDERGOING ELECTIVE GENERAL ABDOMINAL-SURGERY - RELATION TO MAJOR THROMBOEMBOLISM AND MORTALITY, Thrombosis research, 80(6), 1995, pp. 491-497
Citation: Pa. Flordal, THE PLASMA DILUTION FACTOR - PREDICTING HOW CONCENTRATIONS IN PLASMA AND SERUM ARE AFFECTED BY BLOOD-VOLUME VARIATIONS AND BLOOD-LOSS, The Journal of laboratory and clinical medicine, 126(4), 1995, pp. 353-357
Authors:
BERGQVIST D
BURMARK US
FLORDAL PA
FRISELL J
HALLBOOK T
HEDBERG M
HORN A
KELTY E
KVITTING P
LINDHAGEN A
LJUNGSTROM KG
MATZSCH T
RISBERG B
SYK I
TORNGREN S
WELLANDER E
ORTENWALL P
Citation: D. Bergqvist et al., LOW-MOLECULAR-WEIGHT HEPARIN STARTED BEFORE SURGERY AS PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS - 2500 VERSUS 5000 XAI UNITS IN 2070 PATIENTS, British Journal of Surgery, 82(4), 1995, pp. 496-501
Authors:
BURMARK BD
ESKILSSON C
FLORDAL PA
FRISELL J
HALLBOOK T
HEDBERG M
HORN A
KVITTING P
LINDHAGEN A
LJUNGSTROM KG
MATZSCH T
RISBERG B
SYK I
TORNGREN S
WELLANDER E
ORTENWALL P
Citation: Bd. Burmark et al., LOW-MOLECULAR-WEIGHT HEPARIN (DALTEPARIN) STARTED IN THE EVENING BEFORE SURGERY AS PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS - 2500 COMPAREDWITH 5000 XAI UNITS IN 2097 PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 545-545
Citation: Pa. Flordal et al., HEMOSTATIC DEFECTS IN PATIENTS WITH ACUTE UPPER GASTROINTESTINAL HEMORRHAGE, Thrombosis and haemostasis, 69(6), 1993, pp. 1244-1244
Citation: Pa. Flordal et S. Sahlin, USE OF DESMOPRESSIN TO PREVENT BLEEDING COMPLICATIONS IN PATIENTS TREATED WITH ASPIRIN, British Journal of Surgery, 80(6), 1993, pp. 723-724